Omixon Launches AzureSeq-200 CE IVD Kit For One-step RT-qPCR Detection of SARS-CoV-2 and Announces Exclusive Agreement with SeqOnce Biosciences

As much as Omixon wants to stay focused on the needs of histocompatibility labs, the current coronavirus pandemic calls for innovation in the field of viral detection based on molecular diagnostics. Omixon has used its product development capabilities and collaboration network to develop a truly innovative product addressing an...

 

Read more

Omixon Launches OmniType, Multiplex For NGS-based HLA Genotyping

Omixon proudly announces the launch of OmniType, a 11-locus multiplex human leukocyte antigen (HLA) genotyping assay and software product for use on the Illumina® sequencing platforms (such as MiSeq, MiniSeq and iSeq). OmniType offers a revolutionary single working-day workflow that allows processing of samples from gDNA to a ready-to-sequence...

 

Read more

Essemedical is Omixon’s New Distributor

Omixon welcomes Essemedical s.r.l. as our New Distributor in Italy Omixon is pleased to announce the signature of a Distribution Agreement with Essemedical s.r.l. (Dia4it s.r.l.), based in Vedano al Lambro (MB), Italy. The agreement is effective as of September 1st, 2020. Our cooperation will provide easier access to Omixon’s high-performance,...

 

Read more